SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028757
Filing Date
2018-11-09
Accepted
2018-11-09 07:57:35
Documents
42
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q wve-10q_20180930.htm 10-Q 1180265
2 EX-10.1 wve-ex101_78.htm EX-10.1 35363
3 EX-10.2 wve-ex102_667.htm EX-10.2 29779
4 EX-31.1 wve-ex311_6.htm EX-31.1 14702
5 EX-31.2 wve-ex312_7.htm EX-31.2 15043
6 EX-32 wve-ex32_8.htm EX-32 9145
7 GRAPHIC gzso5m5uaazh000001.jpg GRAPHIC 44732
  Complete submission text file 0001564590-18-028757.txt   3886303

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT wve-20180930.xml EX-101.INS 702596
9 XBRL TAXONOMY EXTENSION SCHEMA wve-20180930.xsd EX-101.SCH 27094
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20180930_cal.xml EX-101.CAL 33242
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20180930_def.xml EX-101.DEF 86628
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20180930_lab.xml EX-101.LAB 216067
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20180930_pre.xml EX-101.PRE 167902
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 181171406
SIC: 2834 Pharmaceutical Preparations